Review: taking Alphagan and Hctz together


Summary

Drug interactions are reported among people who take Alphagan and Hctz together. This review analyzes the effectiveness and drug interactions between Alphagan and Hctz. It is created by eHealthMe based on reports of 217 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Alphagan and Hctz >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Alphagan

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. (latest outcomes from Alphagan 3,353 users)

Hctz

Hctz has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. (latest outcomes from Hctz 1,151 users)

On Jul, 28, 2016

217 people who take Alphagan, Hctz are studied.


Number of reports submitted per year:

Alphagan and Hctz drug interactions.

Drug effectiveness over time:

Alphagan:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hctz:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Alphagan:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 1 people)
Hctz:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Alphagan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 33.0% - (1 of 3 people)
Hctz:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure acute
  • syncope
  • mental status changes
  • renal tubular necrosis
  • sepsis syndrome
  • hypertension
  • loss of consciousness
  • blood creatinine increased
  • blood glucose increased
  • blood potassium decreased
1 - 6 months:
  • asthenia
  • blood pressure abnormal
  • blood pressure decreased
  • eye redness
  • fatigue
  • hypersensitivity
  • loss of consciousness
  • nausea
  • rhinorrhoea
  • syncope
1 - 2 years:
  • dizziness
  • fatigue
  • lymphocyte count decreased
  • pruritus
  • chromatopsia
  • cataract
5 - 10 years:
  • arthropathy
  • cardiac murmur
  • dizziness
  • emotional distress
  • hypertension
  • mental disorder
  • pulmonary embolism
  • tinnitus
not specified:
  • dyspnoea
  • asthenia
  • oedema peripheral
  • fall
  • loss of consciousness
  • insomnia
  • pain
  • vomiting
  • pneumonia
  • hypertension

Most common drug interactions by gender *:

female:
  • dyspnoea
  • oedema peripheral
  • vomiting
  • asthenia
  • loss of consciousness
  • fall
  • hypertension
  • pain
  • syncope
  • hypoaesthesia
male:
  • intraocular pressure increased
  • asthenia
  • blood urea increased
  • dizziness
  • mental status changes
  • renal failure acute
  • syncope
  • eye pain
  • pneumonia
  • renal tubular necrosis

Most common drug interactions by age *:

40-49:
  • hypertension
  • abscess
  • angina pectoris
  • anxiety
  • arterial disorder
  • back pain
  • blood glucose increased
  • cardiac valve disease
  • coronary artery atherosclerosis
  • coronary artery disease
50-59:
  • dizziness
  • blindness unilateral
  • blood cholesterol increased
  • eye pain
  • headache
  • optic atrophy
  • optic ischaemic neuropathy
  • retinal aneurysm
  • retinal scar
  • scotoma
60+:
  • dyspnoea
  • loss of consciousness
  • vomiting
  • asthenia
  • syncope
  • pneumonia
  • fall
  • insomnia
  • oedema peripheral
  • blood urea increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Alphagan and Hctz?

Can you answer these questions?

More questions for: Alphagan, Hctz

You may be interested in these reviews

More reviews for: Alphagan, Hctz

On eHealthMe, Alphagan (brimonidine tartrate) is often used to treat glaucoma. Hctz (hydrochlorothiazide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.